(19)
(11) EP 1 011 328 A1

(12)

(43) Date of publication:
28.06.2000 Bulletin 2000/26

(21) Application number: 98940875.2

(22) Date of filing: 14.08.1998
(51) International Patent Classification (IPC)7A01N 37/18
(86) International application number:
PCT/US9816/816
(87) International publication number:
WO 9908/522 (25.02.1999 Gazette 1999/08)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

(30) Priority: 15.08.1997 US 55868 P

(71) Applicants:
  • LUDWIG INSTITUTE FOR CANCER RESEARCH
    New York,New York 10158 (US)
  • HELSINKI UNIVERSITY LICENSING LTD. OY
    00710 Helsinki (FI)
  • University of Geneva
    1211 Geneva 4 (CH)

(72) Inventors:
  • PEPPER, Michael, S.
    1 Rue MIchel Servet, 1211 Geneva 4 (CH)
  • ALITALO, Kari
    SF-0014 University of Helsinki (FI)
  • ERIKSSON, Ulf
    PO Box 240, S-17177 Stockholm (SE)

(74) Representative: Harrison Goddard Foote 
Belmont House,20 Wood Lane
Leeds LS6 2AE
Leeds LS6 2AE (GB)

   


(54) STIMULATION, MODULATION AND/OR INHIBITION OF ENDOTHELIAL PROTEOLYTIC ACTIVITY AND/OR ANGIOGENIC ACTIVITY